Under an agreement struck between the company and the Fukuoka prefectural government earlier this week, they will aim at developing an inhaled drug that can directly work on the patient's lungs, thus having few side effects. KYODONews
Thursday, May 21, 2020
Japanese startup to use RNA technology to develop anti-COVID-19 drug
Under an agreement struck between the company and the Fukuoka prefectural government earlier this week, they will aim at developing an inhaled drug that can directly work on the patient's lungs, thus having few side effects. KYODONews
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment